Ads
related to: pros and cons of strattera- Dosing & Administration
Learn About a Once-Daily Dosing
Option for ADHD Patients.
- ADHD in Adult Patients
Access Resources for Diagnosing
& Treating ADHD in Adult Patients.
- Pediatric ADHD Patients
Resources for Diagnosing & Treating
ADHD in Pediatric Patients.
- Prescriber Resources
Continued Access & Support for
Physicians & Patients Available.
- Review Clinical Studies
Read Clinical Trial Data for a
Nonstimulant ADHD Treatment Option.
- Important Safety Info
Review Important Safety, Dosing,
& Tolerability Information.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Atomoxetine, formerly sold under the brand name Strattera, [12] is a selective norepinephrine reuptake inhibitor (sNRI) medication used to treat attention deficit hyperactivity disorder (ADHD) [13] and, to a lesser extent, cognitive disengagement syndrome (CDS). [14] [15] [16] It may be used alone or along with stimulant medication.
Atomoxetine is sold under the brand name Strattera and was first approved for medical use in the United States in 2002. [1] Its indication is for the treatment of attention deficit hyperactivity disorder (ADHD) in children over 6 years of age, adolescents and adults. [2]
Strattera (atomoxetine) – a non-stimulant medication used to treat ADHD Suboxone ( buprenorphine/naloxone ) - a partial opioid agonist used in the treatment of opioid use disorder T
Norepinephrine Epinephrine. A norepinephrine reuptake inhibitor (NRI, NERI) or noradrenaline reuptake inhibitor or adrenergic reuptake inhibitor (ARI), is a type of drug that acts as a reuptake inhibitor for the neurotransmitters norepinephrine (noradrenaline) and epinephrine (adrenaline) by blocking the action of the norepinephrine transporter (NET).
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved.
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
Ad
related to: pros and cons of strattera